BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 31205538)

  • 1. Challenges of Providing Concordant Interpretation of Somatic Variants in Non-Small Cell Lung Cancer: A Multicenter Study.
    Gao P; Zhang R; Li Z; Ding J; Xie J; Li J
    J Cancer; 2019; 10(8):1814-1824. PubMed ID: 31205538
    [No Abstract]   [Full Text] [Related]  

  • 2. Reliable assessment of BRCA1 and BRCA2 germline variants by next-generation sequencing: a multicenter study.
    Zhang R; Gao P; Han Y; Zhang R; Tan P; Zhou L; Zhang J; Xie J; Li J
    Breast Cancer; 2021 May; 28(3):672-683. PubMed ID: 33400207
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of significant procedures in multigene molecular detection for breast cancer in clinical laboratories: from variant detection to targeted therapy.
    Zhang R; Gao P; Ding J; Li Z; Li J
    Breast Cancer; 2020 Jan; 27(1):111-121. PubMed ID: 31388961
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of Somatic and Germline Variant Interpretation in Hereditary Cancer Genes.
    Moody EW; Vagher J; Espinel W; Goldgar D; Hagerty KJ; Gammon A
    JCO Precis Oncol; 2019 Dec; 3():1-8. PubMed ID: 35100725
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Implementation of next generation sequencing technology for somatic mutation detection in routine laboratory practice.
    Giardina T; Robinson C; Grieu-Iacopetta F; Millward M; Iacopetta B; Spagnolo D; Amanuel B
    Pathology; 2018 Jun; 50(4):389-401. PubMed ID: 29752127
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Data sharing to improve concordance in variant interpretation across laboratories: results from the Canadian Open Genetics Repository.
    Mighton C; Smith AC; Mayers J; Tomaszewski R; Taylor S; Hume S; Agatep R; Spriggs E; Feilotter HE; Semenuk L; Wong H; Lazo de la Vega L; Marshall CR; Axford MM; Silver T; Charames GS; Di Gioacchino V; Watkins N; Foulkes WD; Clavier M; Hamel N; Chong G; Lamont RE; Parboosingh J; Karsan A; Bosdet I; Young SS; Tucker T; Akbari MR; Speevak MD; Vaags AK; Lebo MS; Lerner-Ellis J;
    J Med Genet; 2022 Jun; 59(6):571-578. PubMed ID: 33875564
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of a Highly Curated Somatic Oncology Database to Aid in the Interpretation of Clinically Important Variants in Next-Generation Sequencing Results.
    Yaung SJ; Krishna S; Xi L; Ju C; Palma JF; Schmid M
    J Mol Diagn; 2020 Nov; 22(11):1356-1366. PubMed ID: 32961319
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The characteristics of lung adenocarcinoma driver gene variants detected by high-throughput sequencing and quantitative fluorescence PCR].
    Chen LF; Chen XY; Lin J; Yu XB; Jin L
    Zhonghua Bing Li Xue Za Zhi; 2019 Oct; 48(10):772-778. PubMed ID: 31594041
    [No Abstract]   [Full Text] [Related]  

  • 9. Assessment of Interlaboratory Variation in the Interpretation of Genomic Test Results in Patients With Epilepsy.
    SoRelle JA; Pascual JM; Gotway G; Park JY
    JAMA Netw Open; 2020 Apr; 3(4):e203812. PubMed ID: 32347949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discrepancies between tumor genomic profiling and germline genetic testing.
    Pauley K; Koptiuch C; Greenberg S; Kohlmann W; Jeter J; Colonna S; Werner T; Kinsey C; Gilcrease G; Weis J; Whisenant J; Florou V; Garrido-Laguna I
    ESMO Open; 2022 Aug; 7(4):100526. PubMed ID: 35780590
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conflicting Interpretation of Genetic Variants and Cancer Risk by Commercial Laboratories as Assessed by the Prospective Registry of Multiplex Testing.
    Balmaña J; Digiovanni L; Gaddam P; Walsh MF; Joseph V; Stadler ZK; Nathanson KL; Garber JE; Couch FJ; Offit K; Robson ME; Domchek SM
    J Clin Oncol; 2016 Dec; 34(34):4071-4078. PubMed ID: 27621404
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A classification system for clinical relevance of somatic variants identified in molecular profiling of cancer.
    Sukhai MA; Craddock KJ; Thomas M; Hansen AR; Zhang T; Siu L; Bedard P; Stockley TL; Kamel-Reid S
    Genet Med; 2016 Feb; 18(2):128-36. PubMed ID: 25880439
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutation Spectrum of
    Mao L; Zhao W; Li X; Zhang S; Zhou C; Zhou D; Ou X; Xu Y; Tang Y; Ou X; Hu C; Ding X; Luo P; Yu S
    Pathol Oncol Res; 2021; 27():602726. PubMed ID: 34257561
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Variant Interpretation for Cancer (VIC): a computational tool for assessing clinical impacts of somatic variants.
    He MM; Li Q; Yan M; Cao H; Hu Y; He KY; Cao K; Li MM; Wang K
    Genome Med; 2019 Aug; 11(1):53. PubMed ID: 31443733
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single Circulating-Tumor-Cell-Targeted Sequencing to Identify Somatic Variants in Liquid Biopsies in Non-Small-Cell Lung Cancer Patients.
    Barbirou M; Miller A; Manjunath Y; Ramirez AB; Ericson NG; Staveley-O'Carroll KF; Mitchem JB; Warren WC; Chaudhuri AA; Huang Y; Li G; Tonellato PJ; Kaifi JT
    Curr Issues Mol Biol; 2022 Feb; 44(2):750-763. PubMed ID: 35723337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ultrarapid
    Arcila ME; Yang SR; Momeni A; Mata DA; Salazar P; Chan R; Elezovic D; Benayed R; Zehir A; Buonocore DJ; Rekhtman N; Lin O; Ladanyi M; Nafa K
    JTO Clin Res Rep; 2020 Sep; 1(3):. PubMed ID: 33511359
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sensitive detection methods are key to identify secondary EGFR c.2369C>T p.(Thr790Met) in non-small cell lung cancer tissue samples.
    Keppens C; Dequeker EMC; Rouleau E; 't Hart N; Bubendorf L; Dufraing K; Garrec C; Guéguen P; Lamy A; Marchetti A; Pauwels P; Ryska A; Tack V; Tornillo L; Van Casteren K; von der Thüsen JH; Zwaenepoel K; Lissenberg-Witte B; Thunnissen E; Schuuring E
    BMC Cancer; 2020 May; 20(1):366. PubMed ID: 32357863
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Standardization of Somatic Variant Classifications in Solid and Haematological Tumours by a Two-Level Approach of Biological and Clinical Classes: An Initiative of the Belgian ComPerMed Expert Panel.
    Froyen G; Le Mercier M; Lierman E; Vandepoele K; Nollet F; Boone E; Van der Meulen J; Jacobs K; Lambin S; Vander Borght S; Van Valckenborgh E; Antoniou A; Hébrant A
    Cancers (Basel); 2019 Dec; 11(12):. PubMed ID: 31888289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Performance of ACMG-AMP Variant-Interpretation Guidelines among Nine Laboratories in the Clinical Sequencing Exploratory Research Consortium.
    Amendola LM; Jarvik GP; Leo MC; McLaughlin HM; Akkari Y; Amaral MD; Berg JS; Biswas S; Bowling KM; Conlin LK; Cooper GM; Dorschner MO; Dulik MC; Ghazani AA; Ghosh R; Green RC; Hart R; Horton C; Johnston JJ; Lebo MS; Milosavljevic A; Ou J; Pak CM; Patel RY; Punj S; Richards CS; Salama J; Strande NT; Yang Y; Plon SE; Biesecker LG; Rehm HL
    Am J Hum Genet; 2016 Jun; 98(6):1067-1076. PubMed ID: 27181684
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.